See what Worldwide can do for you, now and later.

Biotechs face many challenges when they begin their development journey. These hurdles can make or break a molecule’s future. Finding out that your chosen CRO can’t cut it halfway through the process is enough to derail even the most successful drug program.
By choosing carefully at the start, you can find one strategic, effective partner to help guide you through the entire process.

Request Information

Are you interested in Worldwide Clinical Trials’ contract research or bioanalytical lab services? Please let us know how we can help by filling out the form below.

NOTE: If you’re a healthy volunteer interested in participating in a clinical trial but have a question, click here.

Let Worldwide help you with these common challenges:

Developing an integrated, big-picture roadmap for your molecule and company.

Worldwide offers full-service assistance, from mid-preclinical phases to commercialization and beyond. By working with a partner that is just as skilled in the nitty-gritty details and infrastructure of early development as it is with late-phase trials, regulatory requirements, and market access, you can get a customized, strategic roadmap to get you where you want to go.

Adapting to changes without losing sight of – or progress toward – the end goal.

When the development process hits inevitable bumps in the road, having the right CRO partner makes all the difference. Knowing how to navigate new hurdles, re-envision the development process, and strategically align with regulatory and industry requirements can help your molecule maximize its success premarket so that it’s ready for an impactful launch. A nimble, responsive, experienced CRO can help you avoid major pitfalls and adjust intelligently to any challenge.

Planning and timing each step in the process to maximize ROI and minimize risk.

There’s a lot that goes into drug development. Having a single partner you can rely on – who knows your drug and company strategy inside and out – means each part of your journey is done with care and forethought about the impact on both the present and future of your program. It also results in fewer interruptions and delays, a more predictable development and regulatory review process, tighter budget control, and a more responsive, in-depth relationship with your CRO.

Only with Worldwide

From start to finish, Worldwide is the one CRO who can truly work as a thoughtful, engaged, responsive partner through the entire range of services you require.

Making Preclinical and Early-Phase
Transitions Seamless

Our Clinical Pharmacology Unit and integrated Bioanalytical Laboratory are located near each other to allow for rapid sample processing and data generation.

Making Preclinical and Early-Phase Transitions Seamless

Biotech firms with a molecule ripe for study can benefit from a strategic research partner sooner rather than later. Our Clinical Pharmacology Unit and integrated Bioanalytical Laboratory are located near each other to allow for rapid sample processing and data generation. Each facility offers leading-edge technologies, advanced clinical and analytical services, and extremely high quality. From protocol concepting and scientific consulting to IND support, and from data and project management to multi-site, first-in-human pharmacokinetic and clinical monitoring, our preclinical and early-phase services take the guesswork – and the hassle – out of moving from preclinical to early clinical phases.

Sherilyn Adcock, PhD., RPh.

Chief Scientific Officer,
Early Phase Development

Lona Sheeran

Senior Vice President, Head of Clinical Pharmacology Services

Full-Service Clinical Trial Support

Our team is constantly on the lookout for efficiencies and opportunities to make your data, budget, and efforts go further through strategic planning and proactive communication with regulatory and program stakeholders.

Full-Service Clinical Trial Support

Once clinical research is underway, you can rely on our broad team of experts to diligently manage your drug development program. Our team is constantly on the lookout for efficiencies and opportunities to make your data, budget, and efforts go further through strategic planning and proactive communication with regulatory and program stakeholders. Advanced biostatistics support, our global network, access to our leadership, and intelligent, adaptive approaches to challenges provide you with the best partner to navigate the difficult road toward approval.

Michael Murphy, MD., PhD.

Chief Medical and
Scientific Officer

Jeffrey Zucker

Senior Vice President, Global
Clinical Operations,
Site Management & Trial
Optimization

Regulatory, Commercialization, and Beyond

We understand that the end goal doesn’t exist in a vacuum. It involves hitting lots of strategic targets along the way.

Regulatory, Commercialization, and Beyond

The end goal for each client may be different. Whatever your strategy – finding a buyer, partnering with big pharma, or marketing the drug yourself – Worldwide can help you get there. That’s because we understand that the end goal doesn’t exist in a vacuum. It involves hitting lots of strategic targets along the way. Through early and ongoing discussions with regulatory bodies, and strategic planning throughout the entire development program, we help ensure our clients and their molecules are prepared for the rigorous review process.
And our services don’t end at a successful product launch. We offer continuing support through real-world evidence gathering, patient-reported outcomes studies, health economic and outcomes research, economic dossiers and modeling, safety surveillance, literature reviews, and more.

Aman Khera

Global Head of Regulatory
Strategy

Jeff Trotter, MBA.

Senior Vice President, Scientific Solutions, Real World Evidence